50 MG Bicalutamide Tablets IP is an androgen receptor inhibitor indicated for use in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analog for the treatment of Stage D2 metastatic carcinoma of the prostate. It is taken with hormone treatment which work by blocking the action of male hormones in the prostate and decreases the growth of tumors. It is praised for its effectiveness, longer shelf life and no side effects. We further ensure the safe packaging of the whole range of 50 MG Bicalutamide Tablets IP.
Pack Size:30 Tablets